pr image

Levetiracetam is a novel antiepileptic drug. It acts by binding to the Synaptic Vesicle Protein (SV2A) which is present on synaptic vesicles and some neuroendocrine cells. Pharmacokinetics of Levetiracetam such as less protein binding and lack of hepatic metabolism make Levetiracetam less susceptible to drug interactions with other anticonvulsants.

Similar Products

© 1987 - 2023 General Pharmaceuticals Limited. All Rights Reserved.

Search Product